Close

Are you in compliance?

Don't miss out! Sign up today for our weekly newsletters and stay abreast of important GRC-related information and news.

×

Status message

Start your free, no obligation 5-day trial to continue exploring with full access.

SFO faces criticism for closing Rolls-Royce, GSK cases

Jaclyn Jaeger | February 22, 2019

The U.K. Serious Fraud Office on 22 February announced the closure of two long-running bribery and corruption cases against British engineering company Rolls-Royce and pharmaceutical giant GlaxoSmithKline.

The investigation into Rolls-Royce resulted in a deferred prosecution agreement, entered into in January 2017, with the company and one of its subsidiaries concerning bribery and corruption to win business in Indonesia, Thailand, India, Russia, Nigeria, China, and Malaysia. Rolls-Royce continues to comply with the terms of the DPA, including in relation to its compliance programme, the SFO said.

“Following further investigation, a detailed review of the available evidence, and an assessment of the public interest, there will be no prosecution of individuals associated with...

Read this single article for $49, or click the subscribe button below to review subscription options.

Enjoy unlimited access to thousands of articles, browse five years of digital magazines, qualify for reduced admission to events, and more.